PeptideDB

M2N12 2376577-06-7

M2N12 2376577-06-7

CAS No.: 2376577-06-7

M2N12 is a potent and selective inhibitor of cell division cycle protein phosphatase 25C (Cdc25C) with IC50 of 0.09 μM.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

M2N12 is a potent and selective inhibitor of cell division cycle protein phosphatase 25C (Cdc25C) with IC50 of 0.09 μM. M2N12 also has the activity to inhibit Cdc25A and Cdc25B, with IC50s of 0.53 μM and 1.39 μM respectively. M2N12 has anticancer effect and may be used in cancer research.

Physicochemical Properties


Molecular Formula C20H16CLN5O2
Molecular Weight 393.8263
Exact Mass 393.099
CAS # 2376577-06-7
Related CAS # M5N36;2832887-40-6
PubChem CID 139600304
Appearance Brown to red solid powder
LogP 3
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 5
Heavy Atom Count 28
Complexity 647
Defined Atom Stereocenter Count 0
SMILES

ClC1C(C2C([H])=C([H])C([H])=NC=2C(C=1N([H])C([H])([H])C1=C([H])N(C([H])([H])C2C([H])=C([H])C(C([H])([H])[H])=C([H])C=2[H])N=N1)=O)=O

InChi Key BDBIMDYALUJAPR-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H16ClN5O2/c1-12-4-6-13(7-5-12)10-26-11-14(24-25-26)9-23-18-16(21)19(27)15-3-2-8-22-17(15)20(18)28/h2-8,11,23H,9-10H2,1H3
Chemical Name

6-chloro-7-[[1-[(4-methylphenyl)methyl]triazol-4-yl]methylamino]quinoline-5,8-dione
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro M2N12 (0-20 μM; 72 hours) exhibits cytotoxic activity against A-549, MDA-MB-231, KB, KB-VIN, MCF-7, and HBE tumor cell lines as well as a normal cell line (IC50=3.92 μM, 4.63 μM, 5.05 μM, 6.81 μM, 4.71 μM, and 6.00 μM, respectively)[1].
References

[1]. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries. Eur J Med Chem. 2019 Sep 14;183:111696.


Solubility Data


Solubility (In Vitro) DMSO : 11.11 mg/mL (28.21 mM)
Solubility (In Vivo) Solubility in Formulation 1: 1.11 mg/mL (2.82 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 11.1 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.5392 mL 12.6958 mL 25.3917 mL
5 mM 0.5078 mL 2.5392 mL 5.0783 mL
10 mM 0.2539 mL 1.2696 mL 2.5392 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.